The Business Research Company’s 2026 market reports feature advanced enhancements such as market attractiveness analysis, total addressable market evaluation, company benchmarking matrices, interactive Excel dashboards, expanded supply chain intelligence, emerging startup coverage, and detailed product insights, delivering more actionable and strategically valuable research.
What Market Size Is Forecasted For The Closed Viral Vector Manufacturing Platforms Market By 2030 Based On Its 2026 Value?
The market for closed viral vector manufacturing platforms has experienced significant expansion in recent times. This market is projected to expand from $1.96 billion in 2025 to $2.22 billion by 2026, demonstrating a compound annual growth rate (CAGR) of 13.4%. Factors contributing to this historical growth include an increase in gene therapy clinical trials, the expanded application of viral vectors in vaccine creation, the broadening of cell and gene therapy research initiatives, an intensified regulatory emphasis on sterile production, and the initial integration of closed processing techniques.
The market for closed viral vector manufacturing platforms is projected to experience substantial expansion over the upcoming years. This market is anticipated to reach $3.63 billion in 2030, exhibiting a compound annual growth rate (CAGR) of 13.1%. This expansion during the projection period stems from factors such as the heightened commercialization of gene therapies, an escalating need for extensive viral vector supplies, increasing capital allocation towards sophisticated biomanufacturing infrastructure, an enlargement of contract manufacturing capabilities, and a greater emphasis on streamlining and automating processes. Key developments expected in the forecast timeframe encompass a wider uptake of completely closed and automated production systems, an increasing requirement for adaptable viral vector manufacturing platforms, greater incorporation of disposable and modular elements, an extension of comprehensive closed processing workflows, and a heightened commitment to adhering to regulations and preventing contamination.
Download A Free Sample Report For Comprehensive Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=28981&type=smp
What Important Drivers Are Powering The Closed Viral Vector Manufacturing Platforms Market Growth?
An anticipated increase in clinical trials is set to fuel the expansion of the closed viral vector manufacturing platforms market in the future. These trials involve meticulously planned human studies aimed at evaluating the safety, efficacy, and proper application of novel medical treatments or interventions. The demand for such trials is escalating, driven by the increasing necessity for advanced therapies, with the rising incidence of chronic and intricate diseases spurring the creation and assessment of new drugs and treatments to fulfill currently unmet healthcare requirements. Closed viral vector manufacturing platforms play a crucial role in supporting clinical trials by ensuring the consistent and sterile production of viral vectors, thereby guaranteeing the safety and dependability of the therapies being studied. For example, data from December 2024, provided by the UK trade association, the Association of the British Pharmaceutical Industry (ABPI), indicated that the aggregate number of industry-sponsored clinical trials initiated in the UK grew from 411 in 2022 to 426 in 2023. Consequently, the expanding volume of clinical trials is a key factor propelling the growth of the closed viral vector manufacturing platforms market.
Which Segment Divisions Form The Structure Of The Closed Viral Vector Manufacturing Platforms Market?
The closed viral vector manufacturing platforms market covered in this report is segmented –
1) By Product Type: Plasmid Deoxyribonucleic Acid (DNA), Lentiviral Vectors, Adenoviral Vectors, Adeno-Associated Viral Vectors, Retroviral Vectors, Other Product Types
2) By Workflow: Upstream Processing, Downstream Processing, Fill-Finish
3) By Application: Gene Therapy, Vaccines, Cell Therapy, Other Applications
4) By End User: Pharmaceutical And Biotechnology Companies, Academic And Research Institutes, Contract Manufacturing Organizations, Other End Users
Subsegments:
1) By Plasmid Deoxyribonucleic Acid (DNA): Supercoiled DNA, Linearized DNA, Minicircle DNA
2) By Lentiviral Vectors: Integrating Lentiviral Vectors, Non-Integrating Lentiviral Vectors
3) By Adenoviral Vectors: Replication-Deficient Adenoviral Vectors, Replication-Competent Adenoviral Vectors
4) By Adeno-Associated Viral Vectors (AAV): Single-Stranded AAV (ssAAV), Self-Complementary AAV (scAAV)
5) By Retroviral Vectors: Gamma-Retroviral Vectors, Alpha-Retroviral Vectors
6) By Other Product Types: Herpes Simplex Virus (HSV) Vectors, Vaccinia Virus Vectors, Baculovirus Vectors
What Trends Are Affecting The Closed Viral Vector Manufacturing Platforms Market Dynamics?
Leading companies in the closed viral vector manufacturing platforms market are concentrating on creating sophisticated solutions like nitro controllers to mitigate nitrogen-related stress or toxicity within cell cultures. These devices, known as nitro controllers, monitor and adjust nitrogen levels or reactive nitrogen species during bioprocesses, thereby guaranteeing ideal environments for cell proliferation and product generation. As an illustration, Univercells Technologies, a biotechnology firm based in Belgium, introduced the scale-X nitro controller in May 2025. This system is both compact and cost-effective, designed for extensive viral vector and vaccine manufacturing. It functions with 200 m² and 600 m² scale-X nitro bioreactors and accommodates both adherent and suspension cell cultures. The system facilitates the efficient production of AAV, lentiviral vectors, exosomes, and oncolytic viruses. Furthermore, it permits swift scale-up, streamlining the move from research and development to commercial production within eight months.
Which Firms Are Competing In The Closed Viral Vector Manufacturing Platforms Market?
Major companies operating in the closed viral vector manufacturing platforms market are Thermo Fisher Scientific Inc., Merck KGaA, Lonza Group AG, WuXi AppTec, Samsung Biologics Co. Ltd., FUJIFILM Biotechnologies, Oxford Biomedica Plc, Hillgene, Takara Bio Inc., SkyPharma Production SAS, GeneScript ProBio, Obio Technology Corp. Ltd., VectorBuilder, Charles River Laboratories Pvt. Ltd., Creative Biogene, Esco Aster Pte. Ltd., Karma Biotechnologies, Cell and Gene Therapy Catapult, CoJourney, Applied Biological Laboratories Inc., CEVEC Pharmaceuticals, Genesail Biotech Co. Ltd.
Access The Complete Closed Viral Vector Manufacturing Platforms Market Report:
Which Region Holds The Largest Share In The Closed Viral Vector Manufacturing Platforms Market?
North America was the largest region in the Closed Viral Vector Manufacturing Platforms market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the closed viral vector manufacturing platforms market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Access Closed Viral Vector Manufacturing Platforms Market Report for Deeper Competitive Insights
https://www.thebusinessresearchcompany.com/sample.aspx?id=28981&type=smp
Browse Through More Reports Similar to the Global Closed Viral Vector Manufacturing Platforms Market 2026, By The Business Research Company
Viral Vector Manufacturing Market Report 2026
https://www.thebusinessresearchcompany.com/report/viral-vector-manufacturing-global-market-report
Viral And Non Viral Vector Manufacturing Market Report 2026
Oral Expectorant Market Report 2026
https://www.thebusinessresearchcompany.com/report/oral-expectorant-global-market-report
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas: +1 310-496-7795
Asia: +44 7882 955267 & +91 8897263534
Europe: +44 7882 955267
Email us at: marketing@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model